Related Experiment Video
Updated: Jul 10, 2026

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
The evolution of nonlinear mixed effects modeling in pharmacometrics: toward AI-based variational autoencoders
Jan Rohleff1, Gilbert Koch2, Johannes Schropp3
1Department of Mathematics and Statistics, University of Konstanz, Konstanz, Germany.
None:
The evolution of nonlinear mixed effects (NLME) modeling reflects a continuous cycle of innovation based on advances in numerical methods and computational power. This commentary outlines the evolution of NLME modeling that began with linearization-based approaches in the 1980s, progressed through sampling-based methods in the 2000s, and is now entering a new phase shaped by AI. Variational autoencoders bridge classical NLME modeling with AI-based methods allowing the development and application of AI-augmented PMX models. This opens the route for integrating multimodal data and addressing increasingly complex modeling challenges.
Related Concept Videos
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Overview
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...